|
|
Volumn 20, Issue 3, 2002, Pages 158-166
|
|
New drugs and new approaches for the treatment of metastatic urothelial cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
BRIDGED COMPOUND;
CISPLATIN;
DEOXYCYTIDINE;
DOXORUBICIN;
DRUG DERIVATIVE;
GEMCITABINE;
M VAC PROTOCOL;
M-VAC PROTOCOL;
METHOTREXATE;
TAXANE;
TAXOID;
VINBLASTINE;
DRUG THERAPY;
HUMAN;
METASTASIS;
METHODOLOGY;
REVIEW;
URINARY TRACT CANCER;
UROTHELIUM;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRIDGED COMPOUNDS;
CISPLATIN;
DEOXYCYTIDINE;
DOXORUBICIN;
DRUG THERAPY;
HUMANS;
METHOTREXATE;
TAXOIDS;
UROLOGIC NEOPLASMS;
UROTHELIUM;
VINBLASTINE;
MLCS;
MLOWN;
|
|
EID: 0036675237
PISSN: 07244983
EISSN: None
Source Type: Journal
DOI: 10.1007/s00345-002-0275-2 Document Type: Review |
|
Times cited : (32)
|
|
References (83)
|
